These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3811039)

  • 1. Mild metabolic hyperoxaluria and its response to pyridoxine.
    Gill HS; Rose GA
    Urol Int; 1986; 41(5):393-6. PubMed ID: 3811039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.
    Mitwalli A; Ayiomamitis A; Grass L; Oreopoulos DG
    Int Urol Nephrol; 1988; 20(4):353-9. PubMed ID: 3170105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria.
    Yendt ER; Cohanim M
    N Engl J Med; 1985 Apr; 312(15):953-7. PubMed ID: 3974685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of pyridoxine in mild metabolic hyperoxaluria and primary hyperoxaluria (type 1).
    Edwards P; Rose GA
    Urol Int; 1991; 47(3):113-7. PubMed ID: 1771698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria.
    Edwards P; Nemat S; Rose GA
    Urol Res; 1990; 18(6):393-6. PubMed ID: 2100414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria.
    Takei K; Ito H; Masai M; Kotake T
    Urol Int; 1998; 61(3):192-5. PubMed ID: 9933846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients.
    Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Moeding A; Stessman M; Monga M
    Urology; 2011 May; 77(5):1054-8. PubMed ID: 21334732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hyperoxaluria: effect of treatment with vitamin B6 and shock waves.
    Amato M; Donzelli S; Lombardi M; Salvadori M; Carini M; Selli C; Caudarella R
    Contrib Nephrol; 1987; 58():190-2. PubMed ID: 3691125
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria.
    Milliner DS; Eickholt JT; Bergstralh EJ; Wilson DM; Smith LH
    N Engl J Med; 1994 Dec; 331(23):1553-8. PubMed ID: 7969325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of renal failure in the primary hyperoxalurias.
    Watts RW
    Nephron; 1990; 56(1):1-5. PubMed ID: 2234239
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria.
    Kaelin A; Casez JP; Jaeger P
    Urol Res; 2004 Feb; 32(1):61-8. PubMed ID: 14628106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin B6 resistant primary hyperoxaluria type I. Report of 5 cases.
    Streefland M; Donckerwolcke RA
    Helv Paediatr Acta; 1989 Feb; 43(4):313-24. PubMed ID: 2708072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pyridoxine on oxalate dynamics in three cases of primary hyperoxaluria (with glycollic aciduria).
    Watts RW; Veall N; Purkiss P; Mansell MA; Haywood EF
    Clin Sci (Lond); 1985 Jul; 69(1):87-90. PubMed ID: 4064559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperoxaluria and renal calculi].
    Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
    Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of magnesium and pyridoxine supplementation on glycolate induced hyperoxaluria in male albino rats.
    Gulati S; Narula R; Sadhna S; Sidhu H; Wangoo D; Thind SK; Nath R
    Indian J Exp Biol; 1988 Jul; 26(7):525-7. PubMed ID: 3198153
    [No Abstract]   [Full Text] [Related]  

  • 18. Importance of mild hyperoxaluria in the pathogenesis of urolithiasis--new evidence from studies in the Arabian peninsula.
    Robertson WG; Hughes H
    Scanning Microsc; 1993 Mar; 7(1):391-401; discussion 401-2. PubMed ID: 8316808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers.
    Nguyen QV; Kälin A; Drouve U; Casez JP; Jaeger P
    Kidney Int; 2001 Jun; 59(6):2273-81. PubMed ID: 11380831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
    Milliner DS; Wilson DM; Smith LH
    Kidney Int; 2001 Jan; 59(1):31-6. PubMed ID: 11135054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.